Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer

PUBLIC · ORKAAug 24, 2026•about 3 hours ago

Position

Chief Commercial Officer

Company

Oruka Therapeutics

Todd Edwards
Menlo ParkBiotechnologyHealthcareHealth CareTherapeutics

Description

On August 24, 2026, Oruka Therapeutics, Inc. announced the hiring of Todd Edwards as Chief Commercial Officer. This decision was formalized through a letter agreement dated July 22, 2026, and his employment commenced on the same day.

Company Information

Company

Oruka Therapeutics

Location

Menlo Park, California, United States

About

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka's mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as one or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases.

Don't miss Oruka Therapeutics's next move

Get an email the moment Oruka Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Rajiv
Likely contact at this company
••••••••@••••••••

See Rajiv's verified email →

Arjun
Likely contact at this company
••••••••@••••••••

See Arjun's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Oruka Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Oruka Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.